Presented by the Cancer Drug Development Forum (CDDF) in collaboration with the Society for Immunotherapy of Cancer
The fourth Immunotherapy of Cancer Conference (ITOC4) is an international conference on immunotherapy of cancer organized in Europe by CDDF in collaboration with SITC. The conference provides a forum for preclinical and clinical scientists, academia, healthcare professionals and the pharmaceutical industry to discuss early clinical drug developments, and to address the unique challenges of immunotherapy and translational research.
The ITOC 4 program will focus on the latest challenges and innovations in immunotherapy, with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
Chairman of the Scientific Committee
Get more general information, including registration information, here. SITC members, to obtain a discount code to attend this conference, contact firstname.lastname@example.org.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com